Hereditary ovarian cancers: state of the art. Toss Angela et al. Minerva medica 2019 Aug 110(4) 301-319

Main|Search|PHGKB




Last Posted: Aug 01, 2019

---

• BRCA1 and BRCA2 Testing through Next Generation Sequencing in a Small Cohort of Italian Breast/Ovarian Cancer Patients: Novel Pathogenic and Unknown Clinical Significance Variants.
  Concolino Paola et al. International journal of molecular sciences 2019 Jul 20(14)
• Hereditary ovarian cancers: state of the art.
  Toss Angela et al. Minerva medica 2019 Aug 110(4) 301-319
• Screening and surgical prophylaxis for hereditary cancer syndromes with high risk of endometrial and ovarian cancer.
  Bercow Alexandra S et al. Journal of surgical oncology 2019 Jul
• Somatic variants of potential clinical significance in the tumors of BRCA phenocopies.
  Buckingham Lela et al. Hereditary cancer in clinical practice 2019 1721
• Ovarian Cancer Risk Influenced by Vaginal Microbiome?
  P Harrison, eMdscape, July 2019
• Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database.
  Dominguez-Valentin Mev et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 Jul
• Assessing the effectiveness of the National Comprehensive Cancer Network genetic testing guidelines in identifying African American breast cancer patients with deleterious genetic mutations.
  Ademuyiwa Foluso O et al. Breast cancer research and treatment 2019 Jul
• Liquid biopsy-based comprehensive gene mutation profiling for gynecological cancer using CAncer Personalized Profiling by deep Sequencing.
  Iwahashi Naoyuki et al. Scientific reports 2019 Jul 9(1) 10426
• Evaluating BRCA mutation risk predictive models in a Chinese cohort in Taiwan.
  Hung Fei-Hung et al. Scientific reports 2019 Jul 9(1) 10229
• Infographic: “What Every Young Woman Needs to Know About Hereditary Breast and Ovarian Cancer”
  CDC, 2019

more